Idiopathic generalized epilepsy: genes and variants

Explore variant evidence for Idiopathic generalized epilepsy across 7 analyzed proteins (GABRA1, CASR, SLC2A1, KCNMA1, ABCB1 and 2 more). Linked ClinVar records include 38 pathogenic or likely pathogenic variants, 239 variants of uncertain significance and 62 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Idiopathic generalized epilepsy

ClinVar pathogenic and likely pathogenic variants linked to Idiopathic generalized epilepsy

VariantPositionProtein partClinical label
CASR E127K127Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
CASR E127A127Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
GABRA1 R214C214ExtracellularPathogenic / likely pathogenic (★★)
CASR R220W220Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
GABRA1 R214H214ExtracellularPathogenic / likely pathogenic (★★)
CASR L125P125Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
GABRA1 T289A289TransmembranePathogenic / likely pathogenic (★★)
SLC2A1 R223P223CytoplasmicPathogenic / likely pathogenic (★★)
CASR V689M689TransmembranePathogenic / likely pathogenic (★★)
GABRA1 R147Q147ExtracellularPathogenic / likely pathogenic (★★)
SLC2A1 R223W223CytoplasmicPathogenic / likely pathogenic (★★)
SLC2A1 R458W458CytoplasmicPathogenic / likely pathogenic (★★)
CASR R66C66Ligand-binding 1 (LB1)Pathogenic / likely pathogenic (★★)
GABRA1 T295I295TransmembranePathogenic / likely pathogenic (★★)
CASR R227Q227Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★★)
GABRA1 P124L124ExtracellularPathogenic / likely pathogenic (★)
GABRA1 T292I292TransmembranePathogenic / likely pathogenic (★)
GABRA1 E277G277CytoplasmicPathogenic / likely pathogenic (★)
GABRA1 S213T213ExtracellularPathogenic / likely pathogenic (★)
CASR E191K191Ligand-binding 2 (LB2)Pathogenic / likely pathogenic (★)
GABRA1 F42L42ExtracellularPathogenic / likely pathogenic (★)
GABRA1 I45T45ExtracellularPathogenic / likely pathogenic (★)
GABRA1 F92S92ExtracellularPathogenic / likely pathogenic (★)
GABRA1 Y187D187ExtracellularPathogenic / likely pathogenic (★)
GABRA1 A188D188ExtracellularPathogenic / likely pathogenic (★)
GABRA1 G251S251ExtracellularPathogenic / likely pathogenic (★)
GABRA1 Y252C252ExtracellularPathogenic / likely pathogenic (★)
GABRA1 M263T263TransmembranePathogenic / likely pathogenic (★)
GABRA1 L267F267TransmembranePathogenic / likely pathogenic (★)
GABRA1 N275K275CytoplasmicPathogenic / likely pathogenic (★)
GABRA1 P280Q280TransmembranePathogenic / likely pathogenic (★)
GABRA1 T288I288TransmembranePathogenic / likely pathogenic (★)
GABRA1 F325L325TransmembranePathogenic / likely pathogenic (★)
SLC2A1 M420I420TransmembranePathogenic / likely pathogenic (★)
GABRA1 Q28H28ExtracellularPathogenic / likely pathogenic (★)
GABRA1 R2K2Pathogenic / likely pathogenic (★)
ABCB1 S893Y893ABC transmembrane type-1 2Pathogenic / likely pathogenic
ZFHX3 P3618Q3618Pathogenic / likely pathogenic

Uncertain variants prioritized for review in Idiopathic generalized epilepsy

VariantPositionProtein partClinical labelEvidence
GABRA1 R214S214ExtracellularConflicting reports (★)+6: 3 other pathogenic changes within 3 positions; R214H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.88
GABRA1 N275S275CytoplasmicUncertain (★★)+6: 2 other pathogenic changes within 3 positions; N275K at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.66
GABRA1 Y187C187ExtracellularUncertain (★★)+6: 2 other pathogenic changes within 3 positions; Y187D at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.96
GABRA1 Y187F187ExtracellularUncertain (★)+6: 2 other pathogenic changes within 3 positions; Y187D at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.729
GABRA1 E277D277CytoplasmicUncertain (★)+6: 3 other pathogenic changes within 3 positions; E277G at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.97

Which prediction tools work for Idiopathic generalized epilepsy

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Same protein, different disease

Diseases related to Idiopathic generalized epilepsy

Frequently asked questions

Which genes have records linked to Idiopathic generalized epilepsy?

This view contains 7 analyzed proteins: GABRA1, CASR, SLC2A1, KCNMA1, ABCB1 and 2 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 38 pathogenic or likely pathogenic variants, 239 variants of uncertain significance and 62 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 5 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 357 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center